Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery DOI

Safa Ali Al-Ani,

Qiao Ying Lee,

Danesha Maheswaran

и другие.

Molecular Biotechnology, Год журнала: 2024, Номер unknown

Опубликована: Сен. 13, 2024

Язык: Английский

Recent advances in extracellular vesicles for therapeutic cargo delivery DOI Creative Commons
Hyo In Kim, Jin Bong Park, Yin Zhu

и другие.

Experimental & Molecular Medicine, Год журнала: 2024, Номер 56(4), С. 836 - 849

Опубликована: Апрель 1, 2024

Abstract Exosomes, which are nanosized vesicles secreted by cells, attracting increasing interest in the field of biomedical research due to their unique properties, including biocompatibility, cargo loading capacity, and deep tissue penetration. They serve as natural signaling agents intercellular communication, inherent ability carry proteins, lipids, nucleic acids endows them with remarkable therapeutic potential. Thus, exosomes can be exploited for diverse applications, chemotherapy, gene therapy, photothermal therapy. Moreover, capacity homotypic targeting self-recognition provides opportunities personalized medicine. Despite advantages novel agents, there several challenges optimizing efficiency structural stability defining exosome origins. Future should include development large-scale, quality-controllable production methods, refinement drug strategies, extensive vivo studies clinical trials. unresolved difficulties, use efficient, stable, safe delivery systems is an interesting area research. Therefore, this review describes summarizes cutting-edge published high-impact journals that have introduced or enhanced effects using a system past 2 years. We provide informative overview current state research, highlighting properties applications exosomes. also emphasize future directions, underscoring importance addressing key issues field. With review, we encourage researchers further develop exosome-based drugs application, such may among most promising next-generation therapeutics.

Язык: Английский

Процитировано

72

Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS DOI

Huoli Hu,

Wenjia Zhang, Yundong Zhou

и другие.

Advanced Composites and Hybrid Materials, Год журнала: 2024, Номер 7(6)

Опубликована: Окт. 23, 2024

Язык: Английский

Процитировано

20

Akkermansia muciniphila attenuated lipopolysaccharide-induced acute lung injury by modulating the gut microbiota and SCFAs in mice DOI Creative Commons
Jian Shen, Shuting Wang, Xia He

и другие.

Food & Function, Год журнала: 2023, Номер 14(23), С. 10401 - 10417

Опубликована: Янв. 1, 2023

Gut microbiota are closely related to lipopolysaccharide (LPS)-induced acute lung injury (ALI). Akkermansia muciniphila (A. muciniphila) maintains the intestinal barrier function and regulates balance of reduced glutathione/oxidized glutathione. However, it may be useful as a treatment strategy for LPS-induced injury. Our study aimed explore whether A. could improve by affecting gut microbiota. The administration effectively attenuated tissue damage significantly decreased oxidative stress inflammatory reaction induced LPS, with lower levels myeloperoxidase (MDA), enhanced superoxide dismutase (SOD) activity, pro-inflammatory cytokine levels, macrophage neutrophil infiltration. Moreover, maintained function, reshaped disordered microbial community, promoted secretion short-chain fatty acids (SCFAs). downregulated expression TLR2, MyD88 NF-kappa B (P < 0.05). Butyrate supplementation demonstrated significant improvement in response 0.05) mitigation histopathological mice ALI, thereby restoring butyric acid concentration. In conclusion, our findings indicate that inhibits accumulation cytokines attenuates activation TLR2/Myd88/NF-κB pathway due exerting anti-inflammatory effects through butyrate. This provides an experimental foundation potential application butyrate prevention ALI.

Язык: Английский

Процитировано

27

Genetically engineered loaded extracellular vesicles for drug delivery DOI

Zuriñe Erana-Perez,

Manoli Igartúa, Edorta Santos‐Vizcaíno

и другие.

Trends in Pharmacological Sciences, Год журнала: 2024, Номер 45(4), С. 350 - 365

Опубликована: Март 19, 2024

Язык: Английский

Процитировано

11

Advances in nanomaterial-targeted treatment of acute lung injury after burns DOI Creative Commons
Shuo Zhang, Xinyu Zhao,

Yuhao Xue

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Июнь 18, 2024

Abstract Acute lung injury ( ALI ) is a common complication in patients with severe burns and has complex pathogenesis high morbidity mortality rates. A variety of drugs have been identified the clinic for treatment ALI, but they toxic side effects caused by easy degradation body distribution throughout body. In recent years, as understanding mechanism underlying improved, scholars developed new nanomaterials that can be safely effectively targeted ALI. Most these methods involve such lipids, organic polymers, peptides, extracellular vesicles or cell membranes, inorganic nanoparticles other nanomaterials, which are to reach tissues perform their functions through active targeting passive targeting, process involves cells organelles. this review, first, mechanisms pathophysiological features occurrence after burn reviewed, potential therapeutic targets summarized, existing classified, possible problems challenges discussed provide reference development

Язык: Английский

Процитировано

10

TSG6‐Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model DOI
H. Sun, Jie Dong, Zhaoyue Fu

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(21)

Опубликована: Апрель 8, 2024

Intrauterine adhesion (IUA) is characterized by the formation of fibrous scar tissue within uterine cavity, which significantly impacts female reproductive health and even leads to infertility. Unfortunately, severe cases IUA currently lack effective treatments. This study presents a novel approach that utilizes tumor necrosis factor-(TNF) stimulated gene 6 (TSG6)-modified exosomes (Exos) in conjunction with an injectable thermosensitive hydrogel (CS/GP) mitigate occurrence reducing endometrium fibrosis mouse model. demonstrate TSG6-modified Exos effectively inhibits activation inflammatory M1-like macrophages during initial stages inflammation maintains balance macrophage phenotypes (M1/M2) repair phase. Moreover, TSG6 interaction between endometrial stromal fibroblasts, thereby preventing fibroblasts into myofibroblasts. Furthermore, this research indicates CS/GP facilitates sustained release Exos, leading significant reduction both manifestations extent fibrosis. Collectively, through successful construction loaded progression achieved mitigating Consequently, holds promise for treatment IUA.

Язык: Английский

Процитировано

8

Surface Components and Biological Interactions of Extracellular Vesicles DOI
Jinping Wang, Kuoran Xing, Guo-Ying Zhang

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Фев. 25, 2025

Extracellular vesicles (EVs) are critical mediators of intercellular communication, carrying bioactive cargo and displaying diverse surface components that reflect their cellular origins functions. The EV surface, composed proteins, lipids, glycocalyx elements, plays a pivotal role in targeting recipient cells, mediating biological interactions, enabling selective delivery. This review comprehensively examined the molecular architecture surfaces, linking biogenesis to functional diversity, highlights therapeutic diagnostic potential diseases such as cancer cardiovascular disorders. Additionally, we explore emerging applications EVs, including machine-learning-assisted analysis, chemical integration, cross-system combinations. also discusses some key challenges clinical translation EV-related technologies.

Язык: Английский

Процитировано

1

Engineered extracellular vesicle-based gene therapy for the treatment of discogenic back pain DOI Creative Commons
Shirley Tang, Ana I. Salazar‐Puerta, Mary K. Heimann

и другие.

Biomaterials, Год журнала: 2024, Номер 308, С. 122562 - 122562

Опубликована: Апрель 1, 2024

Painful musculoskeletal disorders such as intervertebral disc (IVD) degeneration associated with chronic low back pain (termed "Discogenic pain", DBP), are a significant socio-economic burden worldwide and contribute to the growing opioid crisis. Yet there very few if any successful interventions that can restore tissue's structure function while also addressing symptomatic pain. Here we have developed novel non-viral gene therapy, using engineered extracellular vesicles (eEVs) deliver developmental transcription factor FOXF1 degenerated IVD in an vivo model. Injured IVDs treated eEVs loaded demonstrated robust sex-specific reductions behaviors compared control groups. Furthermore, restoration of animals were observed, increases height, tissue hydration, proteoglycan content, mechanical properties. This is first study successfully modulating animal model DBP eEV-based delivery genes. Such strategy be readily translated other painful disorders.

Язык: Английский

Процитировано

7

Anti-inflammatory effect of dental pulp stem cells DOI Creative Commons

FenYao Li,

Xinxin Wang, Jin Shi

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Ноя. 23, 2023

Dental pulp stem cells (DPSCs) have received a lot of attention as regenerative medicine tool with strong immunomodulatory capabilities. The excessive inflammatory response involves variety immune cells, cytokines, and has considerable impact on tissue regeneration. use DPSCs for controlling inflammation the purpose treating inflammation-related diseases autoimmune disorders such supraspinal nerve inflammation, pulmonary airways, systemic lupus erythematosus, diabetes mellitus is likely to be safer more than traditional medicines. mechanism anti-inflammatory effects relatively complex, it may that they themselves or some substances secrete regulate through immune-related signaling pathways. Most current studies are still at laboratory cellular level animal model level, believed efforts researchers, DPSCs/SHED expected transformed into excellent drugs clinical treatment related diseases.

Язык: Английский

Процитировано

13

Endothelium‐Derived Engineered Extracellular Vesicles Protect the Pulmonary Endothelial Barrier in Acute Lung Injury DOI Creative Commons
Zhengyan Gu,

Mingxue Sun,

Jihao Liu

и другие.

Advanced Science, Год журнала: 2023, Номер 11(6)

Опубликована: Дек. 7, 2023

Abstract Acute lung injury (ALI) is a severe respiratory disease with high mortality rate. The integrity of the pulmonary endothelial barrier influences development and prognosis ALI. Therefore, it has become an important target for ALI treatment. Extracellular vesicles (EVs) are promising nanotherapeutic agents against Herein, endothelium‐derived engineered extracellular (eEVs) that deliver microRNA‐125b‐5p (miRNA‐125b) to tissues exerting protective effect on reported. eEVs modified microvascular cell‐targeting peptides (LET) exhibit prolonged retention time in targeted cells vivo vitro. To improve efficacy EVs, miRNA‐125b loaded into EVs. Finally, LET‐EVs‐miRNA‐125b constructed. results show compared miRNA‐125b, EVs‐miRNA‐125b, most significant treatment Moreover, found have by inhibiting cell apoptosis, promoting angiogenesis, protecting intercellular junctions. Sequencing analysis reveals downregulates early growth response‐1 (EGR1) levels, which may be potential mechanism action. Taken together, these findings suggest can treat integrity.

Язык: Английский

Процитировано

13